Pharmacokinetics and Safety of a Single Dose and Multiple Doses of Allisartan Isoproxil, an Angiotensin II Receptor Blocker, in Healthy Chinese People-Reference-Cited by-同舟云学术

Pharmacokinetics and Safety of a Single Dose and Multiple Doses of Allisartan Isoproxil, an Angiotensin II Receptor Blocker, in Healthy Chinese People

Published:2021-07-08 Issue:1 Volume:11 Page:43-50
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:Clinical Pharm in Drug Dev

Author:

Yi Wu¹²,Yan Peiyuan³,Lin Sisi²,Hao Rui²,Wang Yannan²,Yu Jin²,Fang Lu²,Zhu Jingjing²,Zhao Di²,Tong Shengjia²,Si Yongkai²,Ye Tiantian²,Wu Zeyu²,Qin Zhiquan³,Huang Hua⁴,Deng Chongyang⁴,Sun Jingchao⁴,Wang Ying²⁵

Affiliation:

1. Department of Clinical Medicine, Medical College of Soochow University Suzhou China

2. Phase I Clinical Research Center Zhejiang Provincial People's Hospital People's Hospital of Hangzhou Medical College Hangzhou China

3. Medical Oncology Wang jiang shan Inpatient Area Zhejiang Provincial People's Hospital People's Hospital of Hangzhou Medical College Hangzhou China

4. Shenzhen Salubris Pharmaceuticals Co., Ltd Shenzhen China

5. Clinical Research Institute Zhejiang Provincial People's Hospital People's Hospital of Hangzhou Medical College Hangzhou China

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpdd.995

Reference18 articles.

1. Comparative effectiveness of an angiotensin receptor blocker, olmesartan medoxomil, in older hypertensive patients

2. The clinical efficacy of angiotensin II type1 receptor blockers on inflammatory markers in patients with hypertension: a multicenter randomized-controlled trial; MUSCAT-3 study

3. C-Reactive Protein and the Risk of Developing Hypertension

4. Angiotensin II type‐2 receptor‐specific effects on the cardiovascular system;Li Y;Cardiovasc Diagn Ther,2012

5. The effect of angiotensin receptor blockers on C‐reactive protein and other circulating inflammatory indices in man;Del Fiorentino A;Vasc Health Risk Manage,2009

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety evaluation of Allisartan Isoproxil in patients with hypertension: a meta-analysis;Frontiers in Cardiovascular Medicine;2024-06-06

2. Pharmacokinetics and Drug–Drug Interaction of Allisartan Isoproxil and Indapamide Sustained‐Release Formulation;Clinical Pharmacology in Drug Development;2023-10-10

3. Comparison of Pharmacokinetics and Bioavailability of Fixed‐Dose Combination Tablet and Monotherapy Combination of Allisartan Isoproxil and Indapamide Sustained‐Release in Healthy Chinese Volunteers;Clinical Pharmacology in Drug Development;2023-09-10